A New Approach to
Treating Autism-Related Irritability
If your teen has a diagnosis of autism and struggles with challenging behaviors like aggression, destruction, self-harming, isolation and meltdowns, they may qualify to participate in our clinical trial for a potential new treatment, offering families an alternative to anti-psychotic treatments.
Who is this study for?
Who is this study for?
Male or female teens may qualify for this study if they meet the following criteria:
-
Are age 13 to 17
-
Have been diagnosed with ASD
-
Experience irritability
The TAPESTRY Study trial coordinator will complete screening assessments to determine if your child is suitable for this study.
What will participants receive?
If your child qualifies for this study, they will receive, at no cost:
-
The investigational drug or placebo
-
All study-related assessments conducted by trained staff at our clinical sites
Health insurance is not required to take part in this study.
Where are the study locations?
The TAPESTRY study is being conducted at 25 major clinical centers in the United States, Australia and New Zealand.